A previous study has demonstrated that MCT1 expression is low in the spinal cord of patients with ALS and in a transgenic (SOD1G93A) ALS animal model, indicating that MCT1 dysfunction in oligodendrocyte MCT1 are linked to neurodegeneration [34]. The gene discussed is SLC16A1; the disease is amyotrophic lateral sclerosis.